Compare OBK & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBK | ALMR |
|---|---|---|
| Founded | 1912 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2018 | 2026 |
| Metric | OBK | ALMR |
|---|---|---|
| Price | $53.80 | $28.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $46.67 | N/A |
| AVG Volume (30 Days) | 144.2K | ★ 203.9K |
| Earning Date | 04-22-2026 | N/A |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.43 | N/A |
| Revenue Next Year | $5.79 | N/A |
| P/E Ratio | $27.40 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $32.13 | $21.58 |
| 52 Week High | $55.57 | $29.43 |
| Indicator | OBK | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 63.75 |
| Support Level | $50.42 | $23.69 |
| Resistance Level | $55.57 | $28.35 |
| Average True Range (ATR) | 1.12 | 1.84 |
| MACD | -0.01 | 0.26 |
| Stochastic Oscillator | 66.67 | 79.93 |
Origin Bancorp Inc is a financial holding company that provides personalized, relationship banking to businesses, municipalities, and personal clients in the communities it serves. The company offers a broad range of financial services and operates more than 56 locations in Dallas/Fort Worth, East Texas, Houston, North Louisiana, Mississippi, South Alabama, and the Florida Panhandle. It also provides insurance agency products and services through its wholly owned insurance agency subsidiary. The company operates in one business segment, community banking, and is mainly engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.